抄録
At the Joint Conference in the last year, total 32 FDA officers and 24 speakers spoke according to common theme “Modernization based on harmonization, implementation and science to achieve future vision” and there were hot discussions at each session.
As a course of story, I select presentations related to important matters such as ICH Q Trio, challenges in global market development and drug production and development by scientific business approach, and report the summary.
